Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines

Paul W. X. Foley; Clara E. Addison; Stephanie B. Whinney; Kiran Patel; David Cunningham; Michael P. Frenneaux; Francisco Leyva

doi:10.1111/j.1540-8159.2008.02268.x

Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines

Paul W. X. Foley, Clara E. Addison, Stephanie B. Whinney, Kiran Patel, David Cunningham, Michael P. Frenneaux, Francisco Leyva

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

To estimate the proportion of patients eligible for implantable cardioverter defibrillator (ICD) therapy for the primary prevention of sudden cardiac death after a myocardial infarction (MI), according to the current guidelines.

Original language	English
Pages (from-to)	S131-S134
Number of pages	4
Journal	Pacing and Clinical Electrophysiology
Volume	32
Issue number	Suppl 1
DOIs	https://doi.org/10.1111/j.1540-8159.2008.02268.x
Publication status	Published - Mar 2009

Keywords

Aged
Australasia
Death, Sudden, Cardiac
Defibrillators, Implantable
Europe
Female
Guideline Adherence
Humans
Internationality
Male
Myocardial Infarction
North America
Practice Guidelines as Topic

Access to Document

10.1111/j.1540-8159.2008.02268.x

Cite this

Foley, P. W. X., Addison, C. E., Whinney, S. B., Patel, K., Cunningham, D., Frenneaux, M. P., & Leyva, F. (2009). Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines. Pacing and Clinical Electrophysiology, 32(Suppl 1), S131-S134. https://doi.org/10.1111/j.1540-8159.2008.02268.x

@article{9b2c9eb1880b46f0a1a89389587133a7,

title = "Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines",

abstract = "To estimate the proportion of patients eligible for implantable cardioverter defibrillator (ICD) therapy for the primary prevention of sudden cardiac death after a myocardial infarction (MI), according to the current guidelines.",

keywords = "Aged, Australasia, Death, Sudden, Cardiac, Defibrillators, Implantable, Europe, Female, Guideline Adherence, Humans, Internationality, Male, Myocardial Infarction, North America, Practice Guidelines as Topic",

author = "Foley, {Paul W. X.} and Addison, {Clara E.} and Whinney, {Stephanie B.} and Kiran Patel and David Cunningham and Frenneaux, {Michael P.} and Francisco Leyva",

year = "2009",

month = mar,

doi = "10.1111/j.1540-8159.2008.02268.x",

language = "English",

volume = "32",

pages = "S131--S134",

journal = "PACE-Pacing and Clinical Electrophysiology",

issn = "0147-8389",

publisher = "Wiley",

number = "Suppl 1",

}

Foley, PWX, Addison, CE, Whinney, SB, Patel, K, Cunningham, D, Frenneaux, MP & Leyva, F 2009, 'Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines', Pacing and Clinical Electrophysiology, vol. 32, no. Suppl 1, pp. S131-S134. https://doi.org/10.1111/j.1540-8159.2008.02268.x

Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines. / Foley, Paul W. X.; Addison, Clara E.; Whinney, Stephanie B. et al.

In: Pacing and Clinical Electrophysiology, Vol. 32, No. Suppl 1, 03.2009, p. S131-S134.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: Implications of international guidelines

AU - Foley, Paul W. X.

AU - Addison, Clara E.

AU - Whinney, Stephanie B.

AU - Patel, Kiran

AU - Cunningham, David

AU - Frenneaux, Michael P.

AU - Leyva, Francisco

PY - 2009/3

Y1 - 2009/3

N2 - To estimate the proportion of patients eligible for implantable cardioverter defibrillator (ICD) therapy for the primary prevention of sudden cardiac death after a myocardial infarction (MI), according to the current guidelines.

AB - To estimate the proportion of patients eligible for implantable cardioverter defibrillator (ICD) therapy for the primary prevention of sudden cardiac death after a myocardial infarction (MI), according to the current guidelines.

KW - Aged

KW - Australasia

KW - Death, Sudden, Cardiac

KW - Defibrillators, Implantable

KW - Europe

KW - Female

KW - Guideline Adherence

KW - Humans

KW - Internationality

KW - Male

KW - Myocardial Infarction

KW - North America

KW - Practice Guidelines as Topic

U2 - 10.1111/j.1540-8159.2008.02268.x

DO - 10.1111/j.1540-8159.2008.02268.x

M3 - Article

C2 - 19250076

VL - 32

SP - S131-S134

JO - PACE-Pacing and Clinical Electrophysiology

JF - PACE-Pacing and Clinical Electrophysiology

SN - 0147-8389

IS - Suppl 1

ER -